Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
3.690
+0.140 (3.94%)
Nov 4, 2024, 4:00 PM EST - Market closed
Sutro Biopharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Net Income | -124.45 | -106.79 | -119.2 | -105.54 | -32.13 | -55.74 | Upgrade
|
| Depreciation & Amortization | 7.02 | 6.82 | 5.69 | 4.84 | 4.3 | 4.78 | Upgrade
|
| Loss (Gain) From Sale of Investments | -28.01 | -18.99 | -16.57 | 7.24 | -41.01 | -1.46 | Upgrade
|
| Stock-Based Compensation | 24.45 | 24.91 | 26.3 | 23.24 | 11.92 | 10.31 | Upgrade
|
| Other Operating Activities | 32.35 | 16.82 | 2.92 | 6.16 | 0.61 | 0.35 | Upgrade
|
| Change in Accounts Receivable | 3.05 | -28.96 | 5.34 | -6.9 | 0.74 | -3.81 | Upgrade
|
| Change in Accounts Payable | 2.18 | 4.81 | -1.23 | 2.71 | -1.14 | 2.25 | Upgrade
|
| Change in Unearned Revenue | -2.69 | -32.6 | 93.65 | -15.21 | -14.96 | -20.19 | Upgrade
|
| Change in Other Net Operating Assets | 11.38 | 22.37 | 6.64 | 1.77 | 3.87 | -1.52 | Upgrade
|
| Operating Cash Flow | -74.72 | -111.62 | 3.55 | -81.68 | -67.8 | -65.02 | Upgrade
|
| Capital Expenditures | -2.97 | -4.32 | -7.86 | -15.32 | -7.13 | -3.48 | Upgrade
|
| Investment in Securities | -150.83 | 0.39 | -27.17 | -82 | 7.64 | -47.65 | Upgrade
|
| Other Investing Activities | - | - | 0.01 | 0.01 | 0.09 | - | Upgrade
|
| Investing Cash Flow | -153.8 | -3.92 | -35.02 | -97.32 | 0.6 | -51.13 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 25 | - | Upgrade
|
| Total Debt Issued | 25 | - | - | - | 25 | - | Upgrade
|
| Long-Term Debt Repaid | - | -12.5 | -9.38 | - | -10 | -5 | Upgrade
|
| Net Debt Issued (Repaid) | 14.67 | -12.5 | -9.38 | - | 15 | -5 | Upgrade
|
| Issuance of Common Stock | 73.51 | 14.34 | 58.15 | 4.25 | 254.56 | 1.44 | Upgrade
|
| Repurchase of Common Stock | -0.44 | -0.49 | -0.46 | -0.99 | -0.31 | -0.3 | Upgrade
|
| Other Financing Activities | -3.54 | 136.21 | - | - | - | -0.33 | Upgrade
|
| Financing Cash Flow | 84.2 | 137.55 | 48.31 | 3.26 | 269.25 | -4.18 | Upgrade
|
| Net Cash Flow | -144.32 | 22.01 | 16.84 | -175.74 | 202.05 | -120.34 | Upgrade
|
| Free Cash Flow | -77.69 | -115.93 | -4.31 | -97 | -74.93 | -68.5 | Upgrade
|
| Free Cash Flow Margin | -45.87% | -75.41% | -6.36% | -156.76% | -175.39% | -160.30% | Upgrade
|
| Free Cash Flow Per Share | -1.18 | -1.93 | -0.08 | -2.10 | -2.30 | -2.98 | Upgrade
|
| Cash Interest Paid | 0.47 | 1.13 | 1.87 | 2.05 | 1.68 | 1.05 | Upgrade
|
| Cash Income Tax Paid | 15.54 | 0.38 | - | 0.1 | - | - | Upgrade
|
| Levered Free Cash Flow | 20.67 | -30.58 | -38.34 | -59.62 | -38.79 | -28.8 | Upgrade
|
| Unlevered Free Cash Flow | 37.08 | -21.72 | -36.53 | -57.62 | -37.04 | -27.98 | Upgrade
|
| Change in Net Working Capital | -74.92 | -6.67 | -19.93 | 8.81 | 1.71 | 4.98 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.